miR-10a-5p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation

Research output: Contribution to journalJournal articleResearchpeer-review

  • Vaher, Helen
  • Toomas Runnel
  • Egon Urgard
  • Alar Aab
  • Gemma Carreras Badosa
  • Julia Maslovskaja
  • Kristi Abram
  • Liisi Raam
  • Bret Kaldvee
  • Tarmo Annilo
  • Eric R. Tkaczyk
  • Toivo Maimets
  • Cezmi A. Akdis
  • Külli Kingo
  • Ana Rebane

Background: miR-10a-5p has been shown to regulate cancer cell proliferation and invasiveness and endothelial cell inflammatory responses. The function of miR-10a-5p in the skin has not been previously studied. The aim of the current study was to examine miR-10a-5p expression, regulation, and function in keratinocytes (KCs) in association with atopic dermatitis (AD). Methods: The expression of miR-10a-5p and its target genes was analyzed using RT-qPCR, mRNA array analysis, in situ hybridization, and immunofluorescence. The transfection of miRNA mimics, cell cycle distribution analysis, and luciferase assays was used to study miR-10a-5p functions in human primary KCs. Results: miR-10a-5p was found to be upregulated in lesional skin from patients with AD and in proliferating KCs. Array and pathway analysis of IL-1β-stimulated KCs revealed that miR-10a-5p inhibited many genes that affect cell cycle progression and only a few inflammation-related genes. Accordingly, fewer cells in S-phase and reduced proliferation were detected as characteristics of miR-10a-5p-transfected KCs. The influence of miR-10a-5p on cell proliferation was also evident in KCs induced by AD-related cytokines, including IL-4, IL-17, and IL-1β, as measured by the capacity to strongly suppress the expression of the proliferation marker Ki-67. Among AD-related putative direct target genes, we verified hyaluronan synthase 3, a damage-associated positive regulator of KC migration and proliferation, as a direct target of miR-10a-5p. Conclusions: miR-10a-5p inhibits KC proliferation and directly targets hyaluronan synthase 3 and thereby may modulate AD-associated processes in the skin.

Original languageEnglish
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume74
Issue number11
Pages (from-to)2146-2156
Number of pages11
ISSN0105-4538
DOIs
Publication statusPublished - 2019
Externally publishedYes

Bibliographical note

Funding Information:
Funding information This work was supported by European Union through the European Regional Development Fund (Project No. 2014-2020.4.01.15-0012) and Research capacity building through improved knowledge exchange and twinning frameworks for the Centre of Excellence in Translational Medicine (1.01.2016−31.12.2018), Estonian Research Council grants (IUT20-60, PUT1669, PUT1465, MOBJD106) and grants from Leo Foundation (LF17040), the Christine Kühne-Center for Allergy Research and Education (Davos, Switzerland), NIH (K12 CA090625) and Department of Veterans Affairs Clinical Sciences R&D (CSRD) Service Career Development of the United States (Award Number IK2 CX001785).

Publisher Copyright:
© 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

    Research areas

  • allergy, atopic eczema, cell cycle, hyaluronic acid, noncoding RNA

ID: 315463755